Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants

Overview of attention for article published in Science Translational Medicine, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 11 news outlets
blogs: 2 blogs
twitter: 96 X users

facebook: 4 Facebook pages
guideline: 1 clinical guideline source
bluesky: 1 Bluesky user

Readers on

mendeley: 172 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 1 Guideline that references this research output.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on 06 Sep 2020

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.